Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,190.00
Bid: 12,210.00
Ask: 12,214.00
Change: 162.00 (1.35%)
Spread: 4.00 (0.033%)
Open: 12,036.00
High: 12,214.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: Lloyds Banking to Embark on wealth management drive

Thu, 29th Jul 2021 08:23

(Alliance News) - Lloyds Bankings on Thursday followed peer Barclays in announcing a big improvement to second-quarter results, while also restoring its payout and announcing an acquisition to accelerate its push into wealth management.

Lloyds said it swung to a GBP3.91 billion pretax profit in the first half of 2021, from a GBP602 million loss a year earlier.

The lender's net income rose 2.0% to GBP7.56 billion from GBP7.41 billion. Net interest margin was 2.5%, which it guided for the rest of 2021 as well.

Lloyds was boosted by an impairment credit of GBP656 million in the first half, following a GBP3.82 billion hit a year earlier.

It resumed interim dividends by declaring a 0.67 pence per share payout, having not made on in the first half of 2020. The dividend is 18% higher than its 0.57p payout for the second half of 2020.

"During the first six months of 2021, the group has delivered a solid financial performance with continued business momentum, bolstered by an improved macroeconomic outlook for the UK," interim CEO William Chalmers said.

In addition, Lloyds announced plans to acquire investment and retirement platform Embark Group for GBP390 million.

"Embark enhances the group's capabilities to address the attractive mass market and self-directed Wealth segment, completing its Wealth proposition. Embark will also enable the group to re-platform its pensions and retirement proposition, delivering a market-leading platform for intermediaries and significantly strengthening its offering in Retirement, an important growth market," Lloyds said.

Embark, which will become part of Scottish Widows, brings GBP35 billion in assets under administration for 410,000 consumer clients. It has seven UK offices - in London, Bolton, Dundee, Edinburgh, Leeds, Leicester and Swindon - and includes the brands Advance, Horizon, Stocktrade, Vested and The Adviser Centre.

The purchase will have a 30 basis points impact on Lloyds' group CET1 ratio, which sat at 16.7% at the end of the first half.

"Our acquisition of Embark will not only help us serve all of a customer's financial needs in one place, but also sit alongside our existing partnerships which meet the more complex financial planning and investment requirements of mass-affluent and high net-worth customers through Schroders Personal Wealth and Cazenove Capital," explained Antonio Lorenzo, chief executive of Scottish Widows & group director of Insurance & Wealth.

Lloyds shares up 1.4% early Thursday in London, outperforming the wider FTSE 100 index.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: up 0.4% at 7,043.64

----------

Hang Seng: up 3.0% at 26,230.04

Nikkei 225: closed up 0.7% at 27,782.42

DJIA: closed down 127.59 points, 0.4%, at 34,930.93

S&P 500: closed down 0.82 of a point at 4,400.64

Nasdaq Composite: closed up 0.7% at 14,762.58

----------

EUR: up at USD1.1852 (USD1.1807)

GBP: up at USD1.3929 (USD1.3881)

USD: down at JPY109.83 (JPY110.09)

Gold: up at USD1,819.05 per ounce (USD1,800.47)

Oil (Brent): up at USD75.16 a barrel (USD74.62)

(changes since previous London equities close)

----------

ECONOMICS AND GENERAL

----------

Thursday's Key Economic Events still to come

0955 CEST Germany labour market statistics

1100 CEST EU business & consumer surveys

1400 CEST Germany provisional CPI

0930 BST UK monetary & financial statistics

0830 EDT US advance estimate GDP

0830 EDT US unemployment insurance weekly claims report

1030 EDT US EIA weekly natural gas storage report

----------

A shallow 8.2 magnitude earthquake struck off the Alaskan peninsula late Wednesday, the US Geological Survey said, prompting a tsunami warning. The earthquake hit 56 miles southeast of the town of Perryville, the USGS said, with a tsunami warning in effect for south Alaska and the Alaskan peninsula. The US government issued a tsunami warning for Alaska's southeast.

----------

BROKER RATING CHANGES

----------

BARCLAYS CUTS UDG HEALTHCARE TO 'EQUAL WEIGHT' (OVERWEIGHT) - TARGET 1,080 (975) PENCE

----------

HSBC CUTS WIZZ AIR TO 'REDUCE' (HOLD) - PRICE TARGET 4,100 (4,500) PENCE

----------

HSBC CUTS PENNON TO 'REDUCE' (HOLD)

----------

COMPANIES - FTSE 100

----------

Oil major Royal Dutch Shell said it is "stepping up" shareholder returns. Shell said it has rebased its second quarter dividend to 24 US cents, up 38% quarter-on-quarter. For the second quarter of last year, it had declared a 16 cents payout. In addition, Shell is targeting USD2 billion in buybacks which it aims to complete by the end of 2021.Chief Executive Ben van Beurden said: "We are stepping up our shareholder distributions today, increasing dividends and starting share buybacks, while we continue to invest for the future of energy." He added: "Total shareholder distributions for 2021 are expected to be around the middle of the 20-30% range of [cash flow from operations] from the previous four quarters. Our progressive dividend policy to grow dividends per share by 4% annually, subject to board approval, remains unchanged." Shell said it saw "another quarter of operational and financial delivery". It swung to a USD3.43 billion profit attributable to shareholders, from a USD18.13 billion loss a year earlier. Shell posted pretax profit of USD4.13 billion, swinging from a USD23.91 billion loss a year prior. Second quarter total revenue, so including joint-ventures, surged 90% to USD61.76 billion from USD32.49 billion.

----------

Miner Anglo American also set out plans to return USD2 billion to investors. It will buyback USD1 billion, and it declared a special payout of USD0.80 per share, equal to USD1 billion. Finance Director Stephen Pearce explained: "As a result of our prudent approach to capital allocation, including our commitment to our established base dividend policy of returning 40% of underlying earnings to our shareholders, our balance sheet is in a strong position." The buyback will kick off immediately and end "no later" than February 14. In addition, Anglo lifted its regular half-year payout to USD1.71 per share, from USD0.28 a year earlier. Anglo noted that including the buyback and special dividend, its interim payout is USD3.31 per share. In the six months to June 30, Anglo American's revenue more than doubled to USD21.78 billion from USD10.19 billion. Pretax profit surged to USD10.70 billion from USD1.56 billion. CEO Mark Cutifani said: "The first six months of 2021 have seen strong demand and prices for many of our products as economies begin to recoup lost ground, spurred by stimulus measures across the major economies."

----------

AstraZeneca said its Covid vaccine generated USD1.2 billion in sales in the first half of the year. The group added in its interim results statement that it shipped about 319 million doses worldwide during the period, which included USD572 million of sales in Europe and USD455 million in emerging markets. Overall first half revenue was USD15.54 billion, up 23% from a year before. Pretax profit rose 25% to USD2.37 billion. Astra declared an unchanged first interim dividend of USD0.90 per shares. It expects revenue to increase by a low-twenties percentage in the full year.

----------

Brewer and distiller Diageo reported an 81% rise in annual pretax profit to GBP3.71 billion from GBP2.04 billion the year before. Net sales in the financial year that ended June 30 were GBP12.73 billion, up 8% from GBP11.75 billion and up 16% on an organic basis. Volumes rose by 10%, or 11% organically, while Diageo's operating margin improved dramatically to 29.3% from 18.2%. Diageo declared a 72.55 pence total dividend, up 4% from 69.88p in financial 2020.

----------

COMPANIES - GLOBAL

----------

Airbus said it bounced back strongly into profit in the first half of the year as aircraft deliveries rose, leading the company to revise its performance forecasts upwards. Airbus posted a net profit of EUR2.2 billion for the first six months of 2021, compared to a loss of EUR1.9 billion last year as the airline industry was walloped by the Covid-19 pandemic. Airbus said it delivered 297 aircraft between January and June against 196 last year. As clients pay most of the cost of the aircraft upon delivery, revenues jumped 30% to EUR24.6 billion. The European plane manufacturer now expects to deliver 600 planes this year, instead of the previously estimated 566, the number delivered in 2020.

----------

Swiss food and drink company Nestle raised its full-year organic sales growth guidance after reporting higher year-on-year sales and profit in the first half. In the six months ended June 30, Nestle's underlying trade operating profit grew to CHF7.25 billion, around USD7.98 billion, up 1.3% from CHF7.16 billion in the same period a year prior, with an underlying profit margin of 17.4%. Sales also grew modestly in the first half, rising 1.5% to CHF41.76 billion from CHF41.15 billion the year before. Organic growth reached 8.1%, the company said, with real internal growth of 6.8% and pricing up 1.3%. The nutrition firm updated its full-year outlook for 2021, predicting full-year organic sales growth between 5% and 6%.

----------

Anheuser-Busch InBev reported a strong performance in the second quarter of the year, with annual earnings possibly seen growing in the double-digit range. AB InBev is a Leuven, Belgium-based drink and brewing company which owns brands such as Corona and Budweiser. Underlying profit attributable to equity holders surged 45% to USD2.61 billion in the second quarter to end-June from USD1.80 billion a year prior. Revenue rose 21% to USD25.83 billion from USD21.30 billion.

----------

Robinhood has said its mission is to "democratize finance for all", and that stretches to its plan for the company's debut on public markets Thursday. The online investment platform, which is expected to begin trading under the ticker symbol "HOOD" on the Nasdaq, has set aside up to 35% of the shares under its initial public offering for sale to its users. On Wednesday, the company said it raised USD1.9 billion in an initial public offering priced at USD38 per share, at the low end of the range in its prospectus and giving a USD32 billion valuation. Robinhood, whose commission-free stock trading model has been copied by some rivals, had USD81 billion in assets under its custody at the end of March, up from USD14.2 billion at the end of 2019.

----------

Thursday's Shareholder Meetings

Amiad Water Systems Ltd - AGM

Aminex PLC - AGM

B&M European Value Retail SA - AGM

CMC Markets PLC - AGM

De La Rue PLC - AGM

discoverIE Group PLC - AGM

Dr Martens PLC - AGM

GB Group PLC - AGM

Intermediate Capital Group PLC - AGM

Johnson Matthey PLC - AGM

Ovoca Bio PLC - AGM

Palace Capital PLC - AGM

Playtech PLC - GM re Finalto sale

Powerhouse Energy Group PLC - AGM

Tate & Lyle PLC - AGM

Volex PLC - AGM

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.